NASDAQ:VIST - Visterra Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Visterra Inc is a United States-based biotechnology company. The Company uses its Atomic Interaction Network analysis to identify disease targets and design effective therapeutics. The Company's technology is based on its Hierotope Platform, which identifies an area, or epitope, on the target protein, glycoprotein or glycan that is fundamental to its structure and function. The Company's Hierotope Platform is able to identify the region of the protein, or epitope, which is structurally constrained, and thus prevented from mutation over time or under immunological or therapeutic pressure. Its technology for creating potent and therapeutics is powered by the Company's computational tools and techniques, the core of which is called Atomic Interaction Network (AIN) analysis.

Receive VIST News and Ratings via Email

Sign-up to receive the latest news and ratings for VIST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:VIST
CUSIPN/A
Phone+1-617-4981070

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

The Truth About Cryptocurrencies

Visterra (NASDAQ:VIST) Frequently Asked Questions

What is Visterra's stock symbol?

Visterra trades on the NASDAQ under the ticker symbol "VIST."

What is the consensus analysts' recommendation for Visterra?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Visterra in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

When did Visterra IPO?

(VIST) raised $51 million in an IPO on the week of January 30th 2017. The company issued 3,900,000 shares at $12.00-$14.00 per share. Leerink Partners and Stifel acted as the underwriters for the IPO and Needham & Company, Wedbus and PacGrow were co-managers.

Has Visterra been receiving favorable news coverage?

News articles about VIST stock have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Visterra earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the biotechnology company an impact score of 46.11 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Visterra?

Shares of VIST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Visterra?

Visterra's mailing address is 1 Kendall Sq Ste B3301, CAMBRIDGE, MA 02139-1604, United States. The biotechnology company can be reached via phone at +1-617-4981070.


MarketBeat Community Rating for Visterra (NASDAQ VIST)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Visterra and other stocks. Vote "Outperform" if you believe VIST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.